share

Acetamide, n-(5,9-Dihydro-8-Methyl-9-Oxo-4H-Imidazo[1,5,4-De]Quinoxalin-7-Yl)- CAS NO 949159-61-9


Unit Price:

CAS No.:949159-61-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Acetamide, n-(5,9-Dihydro-8-Methyl-9-Oxo-4H-Imidazo[1,5,4-De]Quinoxalin-7-Yl)- is a high-purity, specialized heterocyclic organic compound with the CAS number 949159-61-9. This advanced chemical intermediate is critical for research and development in the pharmaceutical sector, particularly in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by R&D laboratories, fine chemical manufacturers, and pharmaceutical companies engaged in the development of new therapeutic agents.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of complex heterocyclic compounds for potential drug discovery programs.
  • Research Chemical: Used in academic and industrial research to study structure-activity relationships (SAR) and develop new chemical entities.
  • API Synthesis: Serves as a precursor in the multi-step synthesis of potential active pharmaceutical ingredients targeting various disease pathways.
  • Biochemical Research: Employed in the development of enzyme inhibitors or receptor ligands due to its complex fused-ring structure.
  • Fine Chemical Production: Utilized in the manufacture of other high-value, specialized organic compounds for advanced applications.

Basic Information

Item Details
Product Name Acetamide, n-(5,9-Dihydro-8-Methyl-9-Oxo-4H-Imidazo[1,5,4-De]Quinoxalin-7-Yl)-
CAS No. 949159-61-9
Molecular Formula C₁₄H₁₂N₄O₂
Molecular Weight 268.27 g/mol
Synonyms N-(5,9-Dihydro-8-methyl-9-oxo-4H-imidazo[1,5,4-de]quinoxalin-7-yl)acetamide; 7-Acetamido-8-methyl-5,9-dihydro-4H-imidazo[1,5,4-de]quinoxalin-9-one; Acetamide, N-(8-methyl-9-oxo-5,9-dihydro-4H-imidazo[1,5,4-de]quinoxalin-7-yl)-; 949159-61-9; Imidazoquinoxaline acetamide derivative
EINECS Contact for details

Quality Control

Our Acetamide, n-(5,9-Dihydro-8-Methyl-9-Oxo-4H-Imidazo[1,5,4-De]Quinoxalin-7-Yl)- is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for research and pharmaceutical development. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and analytical methods is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. This product is light-sensitive (store away from light).

Specification

Item Specification
Appearance Off-white to light yellow powder
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 97.0%
Loss on Drying ≤ 1.0%
Residue on Ignition ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.